Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × tislelizumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 31 Colorectal Neoplasms 18 Stomach Neoplasms 14 Carcinoma, Hepatocellular 12 Neoplasm Metastasis 9 Esophageal Squamous Cell Carcinoma 9 Advanced Solid Tumor 9 Squamous Cell Carcinoma of Head and Neck 8 Lung Neoplasms 7 Head and Neck Neoplasms 7 Esophageal Neoplasms 7 Solid Tumor 4 Neoplasms 4 Melanoma 4 Colonic Neoplasms 4 Small Cell Lung Carcinoma 3 Sarcoma 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Lymphoma, Follicular 3 Lymphoma 3 Carcinoma, Renal Cell 3 Biliary Tract Neoplasms 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Neuroendocrine Tumors 2 Nasopharyngeal Carcinoma 2 Lymphoma, Large B-Cell, Diffuse 2 Locally Advanced Rectal Cancer 2

Interventions

Cyclophosphamide 8 Biopsy 8 Specimen Handling 7 pembrolizumab 6 fludarabine 6 Whole-Body Irradiation 6 Magnetic Resonance Spectroscopy 6 Peripheral Blood Stem Cell Transplantation 5 Brentuximab Vedotin 5 fludarabine phosphate 4 duvelisib 4 Melphalan 4 10-propargyl-10-deazaaminopterin 4 ruxolitinib 3 X-Rays 3 Mycophenolic Acid 3 Immunoglobulin G 3 Gemcitabine 3 Disulfides 3 tazemetostat 2 sodium-iodide symporter 2 romidepsin 2 cemiplimab 2 belinostat 2 Sirolimus 2 Rituximab 2 Photons 2 Pharmacogenomic Variants 2 Nivolumab 2 Lenalidomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡